Macaques Immunodeficiency Virus-Infected Infant Immunosuppressed Simian tuberculosis Vaccine Strain Is Safe in A Recombinant Attenuated Mycobacterium

Published Ahead of Print 13 June 2012. 10.1128/CVI.00184-12. 2012, 19(8):1170. DOI: Clin. Vaccine Immunol. Michelle H. Larsen and Kristina Abel Paul A. Luciw, William R. Jacobs Jr., Glenn Fennelly, Rompay, Don R. Canfield, Imran Khan, Resmi Ravindran, Kara Jensen, Uma Devi K. Ranganathan, Koen K. A. Van Macaques Immunodeficiency Virus-Infected Infant Immunosuppressed Simian tuberculosis Vaccine Strain Is Safe in A Recombinant Attenuated Mycobacterium

[1]  R. Gie,et al.  A Proposed Comprehensive Classification of Tuberculosis Disease Severity in Children , 2012, The Pediatric infectious disease journal.

[2]  P. Luciw,et al.  Stereological analysis of bacterial load and lung lesions in nonhuman primates (rhesus macaques) experimentally infected with Mycobacterium tuberculosis. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[3]  K. Mansfield,et al.  Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate. , 2011, Vaccine.

[4]  P. Earl,et al.  Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques. , 2011, Vaccine.

[5]  JoAnne L. Flynn,et al.  Understanding Latent Tuberculosis: A Moving Target , 2010, The Journal of Immunology.

[6]  P. Earl,et al.  Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV. , 2010, Vaccine.

[7]  W. Jacobs,et al.  Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice. , 2009, Vaccine.

[8]  S. Porcelli,et al.  Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. , 2009, Tissue antigens.

[9]  B. Eley,et al.  Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants. , 2009, Bulletin of the World Health Organization.

[10]  W. Jacobs,et al.  Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves. , 2009, Vaccine.

[11]  J. Mittler,et al.  A replication clock for Mycobacterium tuberculosis , 2009, Nature Medicine.

[12]  J. Flynn,et al.  Profiling Antibodies to Mycobacterium tuberculosis by Multiplex Microbead Suspension Arrays for Serodiagnosis of Tuberculosis , 2007, Clinical and Vaccine Immunology.

[13]  Bing Chen,et al.  Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. , 2007, The Journal of clinical investigation.

[14]  R. Gie,et al.  The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. , 2007, Vaccine.

[15]  Bing Chen,et al.  Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. , 2006, Vaccine.

[16]  K. Abel,et al.  Rapid Virus Dissemination in Infant Macaques after Oral Simian Immunodeficiency Virus Exposure in the Presence of Local Innate Immune Responses , 2006, Journal of Virology.

[17]  R. Gie,et al.  Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  P. Kozlowski,et al.  Mucosal vaccines: the promise and the challenge , 2006, Nature Reviews Immunology.

[19]  J. Lifson,et al.  Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS , 2005, Journal of medical primatology.

[20]  W. Jacobs,et al.  Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis. , 2005, Microbes and infection.

[21]  Bing Chen,et al.  Long-Term Protection against Tuberculosis following Vaccination with a Severely Attenuated Double Lysine and Pantothenate Auxotroph of Mycobacterium tuberculosis , 2005, Infection and Immunity.

[22]  R. Singh,et al.  The Clinical Benefits of Tenofovir for Simian Immunodeficiency Virus–Infected Macaques Are Larger Than Predicted by its Effects on Standard Viral and Immunologic Parameters , 2004, Journal of acquired immune deficiency syndromes.

[23]  J. Rychert,et al.  Retrovirology BioMed Central , 2004 .

[24]  K. Mansfield,et al.  Body-composition changes in the simian immunodeficiency virus-infected juvenile rhesus macaque. , 2004, The Journal of infectious diseases.

[25]  A. Amedee,et al.  Mother‐to‐infant transmission of SIV via breast‐feeding in rhesus macaques , 2003, Journal of medical primatology.

[26]  P. Earl,et al.  Immunization of Newborn Rhesus Macaques with Simian Immunodeficiency Virus (SIV) Vaccines Prolongs Survival after Oral Challenge with Virulent SIVmac251 , 2003, Journal of Virology.

[27]  Bing Chen,et al.  A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis , 2002, Nature Medicine.

[28]  B. Ryffel,et al.  Enhanced Immune Response in Mycobacterium bovis Bacille Calmette Guerin (BCG)-Infected IL-10-Deficient Mice , 2002, Clinical chemistry and laboratory medicine.

[29]  M. Newport,et al.  Influence of Mycobacterium bovis Bacillus Calmette-Guérin on Antibody and Cytokine Responses to Human Neonatal Vaccination1 , 2002, The Journal of Immunology.

[30]  J. Vekemans,et al.  Tuberculosis Contacts but Not Patients Have Higher Gamma Interferon Responses to ESAT-6 than Do Community Controls in The Gambia , 2001, Infection and Immunity.

[31]  M. Simon,et al.  Antiretroviral Agents Restore Mycobacterium-Specific T-Cell Immune Responses and Facilitate Controlling a Fatal Tuberculosis-Like Disease in Macaques Coinfected with Simian Immunodeficiency Virus andMycobacterium bovis BCG , 2001, Journal of Virology.

[32]  J. Flynn,et al.  Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. , 2000, AIDS research and human retroviruses.

[33]  G. Marchal,et al.  Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice. , 2000, Vaccine.

[34]  M. Newport,et al.  Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. , 1999, Journal of immunology.

[35]  P. Brandtzaeg.  Regionalized immune function of tonsils and adenoids. , 1999, Immunology today.

[36]  M. Simon,et al.  Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis. , 1999, Journal of immunology.

[37]  N. Pedersen,et al.  Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques , 1995, Journal of virology.

[38]  V. Diwan,et al.  Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. , 1993, International journal of epidemiology.

[39]  N. Pedersen,et al.  Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection , 1992, Antimicrobial Agents and Chemotherapy.

[40]  K. Abel.  The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies. , 2009, Current HIV research.

[41]  J. Stockman.  Effect of BCG Vaccination on Childhood Tuberculous Meningitis and Miliary Tuberculosis Worldwide: A Meta-analysis and Assessment of Cost-effectiveness , 2007 .

[42]  H. Maecker,et al.  Bacillus Calmette Guerin Vaccination of Human Newborns Induces a Specific, Functional CD8 T Cell Response , 2006 .

[43]  G. Colditz,et al.  Relationship between bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.